Nobuo Funao
Impact in
- Gastroenterology top 1%
- Gastroesophageal reflux and treatments
- Surgery top 5%
- Helicobacter pylori-related gastroenterology studies
- Eosinophilic Esophagitis
- Gastrointestinal disorders and treatments
Papers in
- Surgery 7
- Helicobacter pylori-related gastroenterology studies 6
- Eosinophilic Esophagitis 4
- Esophageal and GI Pathology 1
-
- Gastroesophageal reflux and treatments 4
- Co-authors
- Akira Nishimura (7 shared papers)Yuuichi Sakurai (4 shared papers)Kazunari Murakami (2 shared papers)Madoka Shiino (2 shared papers)Masahiro Asaka (2 shared papers)Kiyoshi Ashida (5 shared papers)Takashi Kawai (5 shared papers)Kazunori Oda (5 shared papers)
- Journals
- Gastroenterology (6 papers)Gut (4 papers)The Lancet Diabetes & Endocrinology (1 paper)Chinese Medical Journal (1 paper)
- Partner nations
- JapanUnited StatesSpain
In The Last Decade
Nobuo Funao
12 papers receiving 667 citations
Nobuo Funao's Hit Papers
Peers
Comparison fields: 5 of 59
- Gastroenterology 281
- Surgery 421
- Small Animals 49
- Pulmonary and Respiratory Medicine 131
- Endocrinology, Diabetes and Metabolism 37
Countries citing papers authored by Nobuo Funao
This map shows the geographic impact of Nobuo Funao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Funao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Funao more than expected).
Fields of papers citing papers by Nobuo Funao
This network shows the impact of papers produced by Nobuo Funao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Funao. The network helps show where Nobuo Funao may publish in the future.
Co-authors
The 25 scholars most cited alongside Nobuo Funao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study Hit paper breakdown → | 2016 | 331 |
| 2 | 2019 | 92 | |
| 3 | 2017 | 88 | |
| 4 | 2017 | 83 | |
| 5 | 2013 | 44 | |
| 6 | 2024 | 10 | |
| 7 | 2014 | 9 | |
| 8 | 2014 | 8 | |
| 9 | 2014 | 7 | |
| 10 | 2020 | 2 | |
| 11 | 2015 | 1 | |
| 12 | 2018 | 1 |
About Nobuo Funao
Nobuo Funao is a scholar working on Surgery, Gastroenterology, Pharmacology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 12 papers that have together received 676 indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (6 papers), Gastroesophageal reflux and treatments (4 papers), Eosinophilic Esophagitis (4 papers), Inflammatory mediators and NSAID effects (2 papers), Microscopic Colitis (1 paper), Pathogenesis and Treatment of Hiccups (1 paper), Diabetes Treatment and Management (1 paper) and Esophageal and GI Pathology (1 paper). The work is most often cited by research in Gastroenterology (281 citations), Surgery (421 citations), Small Animals (49 citations), Pulmonary and Respiratory Medicine (131 citations) and Endocrinology, Diabetes and Metabolism (37 citations). Nobuo Funao has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Akira Nishimura, Yuuichi Sakurai, Kazunari Murakami, Madoka Shiino, Masahiro Asaka, Kiyoshi Ashida, Takashi Kawai, Kazunori Oda, Kentaro Sugano and Yuji Mizokami. Their work appears in journals such as Gastroenterology, Gut, The Lancet Diabetes & Endocrinology and Chinese Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.